The MAPK/ERK signaling pathway is another vital target for inhibitors. This pathway is included in controling cell survival, differentiation, and growth. Inhibitors targeting MAPK/ERK are used in cancer cells treatments to avoid unrestrained cell spreading and tumor development. Similarly, JAK/STAT signaling inhibitors regulate immune actions and a… Read More